BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 16, 2001
View Archived Issues
Esperion Therapeutics begins phase IIa evaluation of LUV
Read More
Versicor and Biosearch Italia strengthen BIOCOR antiinfective alliance
Read More
Synapse's p97 delivers doxorubicin across BBB in preclinical study
Read More
Xcytrin clinical development program update
Read More
Microcide and J&J companies sign new and amend existing research agreement
Read More
Topical drug delivery technologies licensed by SkyePharma
Read More
Vertex updates progress during past year, provides outlook for this year
Read More
Corixa's RC-529 adjuvant enters phase III for HBV
Read More
Pharmacological characterization of S-18616, a highly potent and selective alpha2-AR agonist
Read More
Innogenetics' HCV therapeutic successfully completes phase I and moves towards phase II
Read More
LIPID substudy confirms beneficial effects of pravastatin in patients with unstable angina
Read More
Viventia Biotech's melanoma vaccine is safe and immunogenic
Read More
Anti-vWF MAb prevents thrombus deposition and neointima formation in guinea pigs
Read More
Protein Design Labs begins phase I/II trial with SMART antibody for Crohn's disease
Read More
Aurora Biosciences and GSK enter ion channel agreement
Read More
European marketing approval announced for noninvasive lung cancer diagnostic
Read More
Watson's Aslera scheduled for March FDA Arthritis Advisory Committee review
Read More
Proteomics-based RA diagnostics alliance formed by Roche and Millennium
Read More
UCB's nonsedating antihistamine approved in Germany
Read More
Authorization for pivotal trials of Generx sought in U.S.
Read More
Aixlie licenses cancer- and immune-related technologies from Ohio State
Read More
Successful phase I results for Enzo Biochem's HIV-1 gene medicine HGTV-43
Read More
Knoll patents compounds useful for depression and other disorders
Read More
Benzenesulfonamide-based inhibitors of ATP-sensitive K+ channels
Read More
DPP IV inhibitors synthesized at MCRF and their use
Read More
Sankyo's new HIV protease inhibitors show nanomolar activity
Read More
Japanese lab presents new series of TNF-alpha production inhibitors
Read More
Natural compounds for obesity with affinity for NPY receptors
Read More
